169 related articles for article (PubMed ID: 3784250)
1. [Effect of verapamil on the indicators of left-ventricular diastole in hypertrophic cardiomyopathy].
Dabrowski M; Górecka B; Witkowski A; Jodkowski J; Woroszylska M; Ruzyłło W
Kardiol Pol; 1986; 29(5-6):345-55. PubMed ID: 3784250
[No Abstract] [Full Text] [Related]
2. [Left ventricular relaxation in hypertrophic cardiomyopathy and possibilities of controlling it with verapamil].
Gregor P; Widimský P; Cervenka V; Vísek V; Sládková T; Dvorák J
Cas Lek Cesk; 1987 Mar; 126(11):330-4. PubMed ID: 3829106
[No Abstract] [Full Text] [Related]
3. Use of verapamil in the treatment of hypertrophic cardiomyopathy.
Gregor P; Widimský P; Cervenka V; Vísek V; Sládková T; Dvorák J
Cor Vasa; 1986; 28(6):404-12. PubMed ID: 3829686
[TBL] [Abstract][Full Text] [Related]
4. [Doppler evaluation of left ventricular diastolic filling after intravenous injection of verapamil in patients with hypertrophic cardiomyopathy].
Jin L; Zhu WL; Mu JL
Zhonghua Nei Ke Za Zhi; 1988 Jul; 27(7):412-4, 454. PubMed ID: 3064997
[No Abstract] [Full Text] [Related]
5. Effect of verapamil on left ventricular isovolumic relaxation time and regional left ventricular filling in hypertrophic cardiomyopathy.
Hanrath P; Mathey DG; Kremer P; Sonntag F; Bleifeld W
Am J Cardiol; 1980 Jun; 45(6):1258-64. PubMed ID: 7189640
[No Abstract] [Full Text] [Related]
6. [Doppler analysis of left-ventricular filling in hypertrophic cardiomyopathy. Preliminary report].
Michalak E; Rydlewska-Sadowska W
Kardiol Pol; 1987; 30(12):798-804. PubMed ID: 3452681
[No Abstract] [Full Text] [Related]
7. [Morphologic indicators of right-ventricular diastolic capacity in hypertrophic cardiomyopathy].
Tendera M; Poloński L; Kozielska E; Wodniecki J
Kardiol Pol; 1984; 27(4):249-55. PubMed ID: 6541726
[No Abstract] [Full Text] [Related]
8. [Characteristics of left-ventricular diastole in hypertrophic cardiomyopathy].
Dabrowski M; Górecka B
Kardiol Pol; 1986; 29(5-6):338-44. PubMed ID: 3784249
[No Abstract] [Full Text] [Related]
9. [Relaxation and regional myocardial stiffness in obstructive hypertrophic cardiopathy patients: effect of verapamil].
Bonandi L; Hess OM; Grimm J; Krayenbühl HP
G Ital Cardiol; 1984 Feb; 14(2):77-84. PubMed ID: 6538857
[TBL] [Abstract][Full Text] [Related]
10. [Effect of single-dose verapamil on ventricular wall movement in hypertrophic cardiomyopathy].
Wang AA; Gu FS
Zhonghua Xin Xue Guan Bing Za Zhi; 1987 Feb; 15(1):25-6. PubMed ID: 3608781
[No Abstract] [Full Text] [Related]
11. [Long-term treatment of hypertrophic non obstructive cardiomyopathy (HNCM) with verapamil (author's transl)].
Kuhn H; Thelen U; Leuner C; Köhler E; Bluschke V
Z Kardiol; 1980 Oct; 69(10):669-75. PubMed ID: 7192910
[No Abstract] [Full Text] [Related]
12. Improved diastolic function and systolic performance in hypertrophic cardiomyopathy after nifedipine.
Lorell BH; Paulus WJ; Grossman W; Wynne J; Cohn PF; Braunwald E
N Engl J Med; 1980 Oct; 303(14):801-3. PubMed ID: 7191052
[No Abstract] [Full Text] [Related]
13. [Effects of verapamil on systolic time intervals and relaxation time in hypertrophic cardiomyopathy (author's transl)].
Hirose K; Shimada T; Matsumura T; Iwata M; Yasunaga K; Hori K; Matsusaka J
J Cardiogr; 1981 Dec; 11(4):1223-32. PubMed ID: 7201494
[TBL] [Abstract][Full Text] [Related]
14. Left ventricular end-diastolic pressure-volume relationships in hypertrophic cardiomyopathy. Changes induced by verapamil.
Tendera M; Polonski L; Kozielska E
Chest; 1983 Jul; 84(1):54-7. PubMed ID: 6683147
[TBL] [Abstract][Full Text] [Related]
15. Hypertrophic obstructive cardiomyopathy. Effects of acute and chronic verapamil treatment on left ventricular systolic and diastolic function.
Anderson DM; Raff GL; Ports TA; Brundage BH; Parmley WW; Chatterjee K
Br Heart J; 1984 May; 51(5):523-9. PubMed ID: 6539120
[TBL] [Abstract][Full Text] [Related]
16. Effects of verapamil on left ventricular systolic function and diastolic filling in patients with hypertrophic cardiomyopathy.
Bonow RO; Rosing DR; Bacharach SL; Green MV; Kent KM; Lipson LC; Maron BJ; Leon MB; Epstein SE
Circulation; 1981 Oct; 64(4):787-96. PubMed ID: 7196813
[TBL] [Abstract][Full Text] [Related]
17. Effects of verapamil on left ventricular diastolic function at rest and during isometric exercise in patients with hypertrophic cardiomyopathy.
Bryhn M; Eskilsson J
Clin Cardiol; 1987 Jan; 10(1):31-6. PubMed ID: 3815911
[TBL] [Abstract][Full Text] [Related]
18. Verapamil-induced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy: short- and long-term effects.
Bonow RO; Dilsizian V; Rosing DR; Maron BJ; Bacharach SL; Green MV
Circulation; 1985 Oct; 72(4):853-64. PubMed ID: 4040821
[TBL] [Abstract][Full Text] [Related]
19. [The effect of verapamil on the left ventricular function in hypertrophic obstructive cardiomyopathy].
Guo HS
Zhonghua Xin Xue Guan Bing Za Zhi; 1984 Mar; 12(1):13-6. PubMed ID: 6540163
[No Abstract] [Full Text] [Related]
20. [Indicators of the diastolic period of the left ventricle].
Górecka B; Dabrowski M
Kardiol Pol; 1986; 29(5-6):409-18. PubMed ID: 3537437
[No Abstract] [Full Text] [Related]
[Next] [New Search]
